Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
The Methodist Hospital Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
VA Office of Research and Development
New Mexico Cancer Research Alliance